Expression of Survivin and Its Splice Variants in Brain Glioma

ZHEN Haining,ZHANG Xiang,FU Luoan,WANG Xiling,LIANG Jingwen,JI Xituan,LI Liwen,ZHANG Rong,SU Mingquan
DOI: https://doi.org/10.3969/j.issn.1671-2897.2005.03.012
2005-01-01
Abstract:Objective To study the role of inhibitor of apoptosis protein Survivin and its splice variants Survivin-Δex3 and Survivin-2B in tumorigenesis and progression of brain glioma.Methods Expression levels of mRNA of Survivin and its splice variants Survivin-Δex3 and Survivin-2B were investigated by reverse transcription polymerase chain reaction (RT-PCR) in 62 cases of brain gliomas and 10 cases of normal brain tissues.Results The positive expression rate of mRNA of Survivin, Survivin-Δex3 and Survivin-2B in brain glioma was 67.7%, 30.6% and 17.7% respectively, while none was expressed in normal brain tissues. There were specially significant difference( P =0.0000.01) and significant difference( P =0.0100.05) respectively between the positive expression rate of mRNA of Survivin and Survivin-Δex3 in brain glioma and those in normal brain tissues. There were specially significant differences( P =0.0020.01, P =0.0040.01)respectively between the positive expression rate of Survivin mRNA in low malignant brain glioma and that in high malignant brain glioma and among those in different pathological grades of glioma.Conclusion Survivin plays an important role, as well as its splice variants Survivin-Δex3 and Survivin-2B play a certain role in tumorigenesis and progression of brain glioma . Survivin is an ideal molecular target for biotherapy of brain glioma.
What problem does this paper attempt to address?